Your browser doesn't support javascript.
loading
Total Synthesis of Pargamicin A.
Elbatrawi, Yassin M; Gerrein, Taylor; Anwar, Avraz; Makwana, Kamlesh M; Degen, David; Ebright, Richard H; Del Valle, Juan R.
Afiliação
  • Elbatrawi YM; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Gerrein T; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Anwar A; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Makwana KM; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
  • Degen D; Waksman Institute and Department of Chemistry & Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States.
  • Ebright RH; Waksman Institute and Department of Chemistry & Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States.
  • Del Valle JR; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
Org Lett ; 24(50): 9285-9289, 2022 12 23.
Article em En | MEDLINE | ID: mdl-36516292
We report the total synthesis and configurational assignment of pargamicin A, a highly oxidized nonribosomal peptide that potently inhibits the growth of drug-resistant bacteria. Our synthetic approach relies on late-stage piperazine ring formation and careful selection of condensation reagents to assemble the densely substituted hexapeptide backbone. This work enables the synthesis of pargamicin congeners for the development of structure-activity relationships and informs strategies for accessing other sterically congested piperazic acid-containing natural products.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Produtos Biológicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Produtos Biológicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article